Delorean’s flagship SA1 Salisbury bioenergy plant is 75% complete, poised to start injecting renewable biomethane into Adelaide’s gas network by November 2026, marking a first in Australia for commercial and industrial organic waste processing.
- SA1 facility 75% constructed, on track for late 2026 commissioning
- Processes 70,000 tonnes organic waste annually into 210 TJ renewable gas
- First Australian plant to inject biomethane from commercial waste streams
- Long-term offtake secured with Origin Energy for biomethane sales
- SA1 serves as blueprint for NSW and Victoria project rollouts in 2026
SA1 Facility Advances Toward Operational Milestone
Delorean Corporation Limited (ASX:DEL) is steadily closing in on a key milestone at its 100%-owned SA1 Salisbury Bioenergy Facility, with construction now 75% complete. The South Australian project remains on schedule to begin accepting organic waste in August 2026 and to inject its first batch of renewable biomethane into the Adelaide gas network by November 2026. This timing positions SA1 as a pioneering facility in Australia, being the first to export biomethane derived from commercial and industrial organic waste streams directly into a gas distribution network.
Construction has progressed across multiple fronts: civil works are substantially finished with asphalt laid and foundations set, while major mechanical equipment including pretreatment and compression systems are installed or en route. Electrical installations and final infrastructure fit-outs are slated to commence mid-June, underpinning the final push toward commissioning. The project maintains a strong safety record, with zero lost time injuries reported.
Renewable Gas and Multiple Revenue Streams
SA1 is designed to process 70,000 tonnes of organic waste annually from Adelaide’s commercial, industrial, and municipal sectors, converting it via anaerobic digestion into approximately 210 terajoules of renewable natural gas (biomethane) per year. Alongside biomethane, the facility will produce 6,000 tonnes of biogenic food-grade liquid CO2 annually, as well as biofertiliser products. It will also generate Australian Carbon Credit Units (ACCUs) and Renewable Gas Guarantee of Origin (RGGO) certificates, adding environmental credit revenue to its portfolio.
The biomethane produced will be sold under a long-term offtake agreement with Origin Energy, supplying industrial customers through the Australian Gas Infrastructure Group’s network in South Australia. This arrangement not only secures a revenue stream but also marks a significant step in integrating renewable gases into existing energy infrastructure.
Template for National Bioenergy Expansion
SA1 is more than just a standalone project; it is the blueprint for Delorean’s broader ambition to roll out shovel-ready bioenergy facilities across Australia. The company plans to commence construction of its NSW1 and VIC1 facilities within 2026, replicating SA1’s capacity, feedstock profile, and product mix. These projects aim to further entrench Delorean’s position in the renewable energy and waste management sectors, leveraging the operational learnings and infrastructure models developed at SA1.
Delorean’s recent capital activities, including a $2.2 million Share Purchase Plan and strategic placements, have been directed at supporting these infrastructure developments, reflecting investor confidence in the company’s growth trajectory. The company’s vertically integrated approach, spanning engineering, infrastructure, and energy retail, provides it with the in-house capability to manage projects end-to-end, from conception through to renewable energy sales.
Investor Engagement and Future Prospects
On 22 May, Delorean hosted an investor site tour at the SA1 construction site, offering stakeholders a tangible view of progress and the scale of operations. This engagement underscores the company’s commitment to transparency and investor relations as it nears a pivotal operational phase.
While the current focus is on commissioning and initial production, Delorean has flagged potential future expansion at SA1, with development approval in place to increase processing capacity from 70,000 to 125,000 tonnes per annum. This expansion would further amplify renewable gas output and associated products, pending market and regulatory conditions.
Delorean’s progress at SA1 builds on a track record of delivering commercial-scale bioenergy facilities in Australia and New Zealand, including projects for Yarra Valley Water. The company’s ability to secure long-term offtake agreements and government grants, such as the $3.8 million ARENA funding milestone, continues to underpin the financial viability of its projects and supports its strategic growth plans.
As Delorean advances its bioenergy infrastructure portfolio, the market will be watching how the company navigates commissioning risks and scales operations, particularly given the pioneering nature of biomethane injection from commercial waste streams in Australia. The successful start-up of SA1 will be a critical proof point for the rollout of subsequent projects in NSW and Victoria.
Investors may find it instructive to consider Delorean’s recent $5.76 million R&D refund which bolsters its development capital, as well as the positive Final Investment Decision for NSW1 that signals confidence in its expansion pipeline.
Bottom Line?
Delorean’s SA1 facility is on the cusp of transforming organic waste into renewable gas at scale, but the transition from construction to reliable operation will be the true test of its pioneering model.
Questions in the middle?
- How will Delorean manage operational risks during SA1’s commissioning phase?
- What are the prospects and timelines for the planned expansion to 125,000 tonnes per annum at SA1?
- How will market demand and regulatory frameworks influence uptake of biomethane and biofertiliser products?